Simona Eleuteri
Overview
Explore the profile of Simona Eleuteri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
502
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Spencer B, Emadi S, Desplats P, Eleuteri S, Michael S, Kosberg K, et al.
Mol Ther
. 2025 Feb;
33(3):1302.
PMID: 39900036
No abstract available.
2.
Eleuteri S, Wang B, Cutillo G, Zhang Fang T, Tao K, Qu Y, et al.
FEBS J
. 2024 Oct;
292(2):332-354.
PMID: 39429232
Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) is a key regulator of mitochondrial biogenesis and antioxidative defenses, and it may play a critical role in Parkinson's disease (PD). F-box/WD repeat...
3.
Fang T, Sun Y, Pearce A, Eleuteri S, Kemp M, Luckhurst C, et al.
Nat Commun
. 2023 Nov;
14(1):7295.
PMID: 37957154
Mutations in SNCA, the gene encoding α-synuclein (αSyn), cause familial Parkinson's disease (PD) and aberrant αSyn is a key pathological hallmark of idiopathic PD. This α-synucleinopathy leads to mitochondrial dysfunction,...
4.
Eleuteri S, Zhang Fang T, Cutillo G, Persico M, Simon D
Res Sq
. 2023 Oct;
PMID: 37886523
Background: In the present study we assessed the protective effects of a pharmacological approach to stabilize the retromer complex in a PD mouse model. Missense mutations in the VPS35 gene...
5.
Ding X, Gao L, Han Z, Eleuteri S, Shi W, Shen Y, et al.
Ageing Res Rev
. 2023 Sep;
91:102077.
PMID: 37742785
Parkinson's Disease (PD) is characterized by the progressive loss of dopaminergic neurons in the substantia nigra (SN), leading to motor and non-motor symptoms. While the exact mechanisms remain complex and...
6.
Dhungel N, Eleuteri S, Li L, Kramer N, Chartron J, Spencer B, et al.
Neuron
. 2023 Jan;
111(1):138.
PMID: 36603548
No abstract available.
7.
8.
Cutillo G, Simon D, Eleuteri S
Neurobiol Dis
. 2020 Aug;
145:105056.
PMID: 32853677
Mutations in VPS35 (PARK17), a key molecule in the retromer complex, are a rare cause of autosomal dominant Parkinson's disease (PD), the second most common neurodegenerative disorder. VPS35 exerts crucial...
9.
Muzio L, Sirtori R, Gornati D, Eleuteri S, Fossaghi A, Brancaccio D, et al.
Nat Commun
. 2020 Aug;
11(1):3848.
PMID: 32737286
Amyotrophic Lateral Sclerosis (ALS) is a fatal disease characterized by the degeneration of upper and lower motor neurons (MNs). We find a significant reduction of the retromer complex subunit VPS35...
10.
Eleuteri S, Albanese A
Front Neurol
. 2020 Jan;
10:1272.
PMID: 31920908
Several symptomatic treatments for Parkinson's disease (PD) are currently available. Still, the challenge today is to find a therapy that might reduce degeneration and slow down disease progression. The identification...